Sarah McDonald

Statistics

Publications

Citations

647

H-Index

Active since

2004

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

Institute of Cancer Research

University of Cambridge

Breast Cancer Now

Queen Mary University of London

Sarah McDonald is an author at Cambridge University Hospitals NHS Foundation Trust specializing in molecular oncology, oncology, and molecular biology.

ORCID

Publications per year

2004–2024

Publications

A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity

Christopher J. Lord, Sarah McDonald, Sally Swift et al. · DNA repair · 2008 · 181 citations

Life Sciences, Genetics, Molecular Biology +15

Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets

Elizabeth Iorns, Christopher J. Lord, Anita Grigoriadis et al. · PLoS ONE · 2009 · 128 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells

Iain Brown, Kawan Shalli, Sarah McDonald et al. · Breast Cancer Research · 2004 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumour gene expression signature in primary melanoma predicts long-term outcomes

Manik Garg, Dominique‐Laurent Couturier, Jérémie Nsengimana et al. · Nature Communications · 2021 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +17

Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance

Anke Nijhuis, Hannah Thompson, Julie Adam et al. · Human Molecular Genetics · 2017 · 61 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 10